Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis

Experimental Eye Research

Volumn 87, Issue 3, 2008, Pages 208-213

  Shindler, Kenneth S ^a   Ventura, Elvira ^b   Dutt, Mahasweta ^a   Rostami, Abdolmohamad ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

axonal loss; demyelination; EAE; optic neuritis; retinal ganglion cell

Indexed keywords

FLUOROGOLD; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AXONAL INJURY; CELL INFILTRATION; CELL LOSS; CONTROLLED STUDY; DEMYELINATION; FEMALE; IMMUNIZATION; NEUROPROTECTION; NONHUMAN; OPTIC NEURITIS; PRIORITY JOURNAL; RETINA GANGLION CELL; SUPERIOR COLLICULUS;

ANIMALS; APOPTOSIS; AXONS; CELL DEATH; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IN SITU NICK-END LABELING; MICE; MICE, INBRED STRAINS; OPTIC NEURITIS; RETINAL GANGLION CELLS;

EID: 50849128802     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.05.017     Document Type: Article

References (31)

1. Arnold A.C. Evolving management of optic neuritis and multiple sclerosis. Am. J. Ophthalmol. 139 (2005) 1101-1108
2. Beck R.W., Cleary P.A., Anderson Jr. M.M., Keltner J.L., Shults W.T., Kaufman D.I., Buckley E.G., Corbett J.J., Kupersmith M.J., Miller N.R., et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N. Engl. J. Med. 326 (1992) 581-588
3. Berkelaar M., Clarke D.B., Wang Y.C., Bray G.M., and Aguayo A.J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14 (1994) 4368-4374
4. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197 (2003) 1073-1081
5. Costello F., Coupland S., Hodge W., Lorello G.R., Koroluk J., Pan Y.I., Freedman M.S., Zackon D.H., and Kardon R.H. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann. Neurol. 59 (2006) 963-969
6. Czasch S., Paul S., and Baumgärtner W. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain. Neurobiol. Aging. 27 (2006) 293-305
7. Davie C.A., Barker G.J., Webb S., Tofts P.S., Thompson A.J., Harding A.E., McDonald W.I., and Miller D.H. Persistent functional deficit in multiple sclerosis and autosomal dominant ataxia associated with axon loss. Brain 118 (1995) 1583-1592
8. Fisher J.B., Jacobs D.A., Markowitz C.E., Galetta S.L., Volpe N.J., Nano-Schiavi M.L., Baier M.L., Frohman E.M., Winslow H., Frohman T.C., Calabresi P.A., Maguire M.G., Cutter G.R., and Balcer L.J. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113 (2006) 324-332
9. Gran B., Zhang G.-X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., and Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169 (2002) 7104-7110
10. Guan Y., Shindler K.S., Tabuena P., and Rostami A. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice. J. Neuroimmunol. 178 (2006) 40-48
11. Guyton M.K., Sribnick E.A., Ray S.K., and Banik N.L. A role for calpain in optic neuritis. Ann. N.Y. Acad. Sci. 1053 (2005) 48-54
12. Hobom M., Storch M.K., Weissert R., Maier K., Radhakrishnan A., Kramer B., Bähr M., and Diem R. Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 14 (2004) 148-157
13. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., Linington C., Schmidbauer M., and Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis. Am. J. Pathol. 157 (2000) 267-276
14. Losseff N.A., Webb S.L., O'Riordan J.I., Page R., Wang L., Barker G.J., Tofts P.S., McDonald W.I., Miller D.H., and Thompson A.J. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119 (1996) 701-708
15. Losseff N.A., Wang L., Lai H.M., Yoo D.S., Gawne-Cain M.L., McDonald W.I., Miller D.H., and Thompson A.J. Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 119 (1996) 2009-2019
16. Maier K., Kuhnert A.V., Taheri N., Sättler M.B., Storch M.K., Williams S.K., Bähr M., and Diem R. Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study. Am. J. Pathol. 169 (2006) 1353-1364
17. Meyer R., Weissert R., Diem R., Storch M.K., de Graaf K.L., Kramer B., and Bahr M. Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 21 (2001) 6214-6220
18. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
19. Parisi V., Manni G., Spadaro M., Colacino G., Restuccia R., Marchi S., Bucci M.G., and Pierelli F. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2520-2527
20. Parry A., Corkill R., Blamire A.M., Palace J., Narayanan S., Arnold D., Styles P., and Matthews P.M. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis. J. Neurol. 250 (2003) 171-178
21. Potter N.T., and Bigazzi P.E. Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein. Invest. Ophthalmol. Vis. Sci. 33 (1992) 1717-1722
22. Qi X., Lewin A.S., Sun L., Hauswirth W.W., and Guy J. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 48 (2007) 681-691
23. Qi X., Hauswirth W.W., and Guy J. Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis. Mol. Vis. 13 (2007) 1-11
24. Sättler M.B., Merkler D., Maier K., Stadelmann C., Ehrenreich H., Bähr M., and Diem R. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ. 11 Suppl. 2 (2004) S181-S192
25. Shao H., Huang Z., Sun S.L., Kaplan H.J., and Sun D. Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse. Invest. Ophthalmol. Vis. Sci. 45 (2004) 4060-4065
26. Shindler K.S., Ventura E., Rex T.S., Elliott P., and Rostami A. SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3602-3609
27. Shindler K.S., Guan Y., Ventura E., Bennett J., and Rostami A. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult. Scler. 12 (2006) 526-532
28. Steel D.H.W., and Waldock A. Measurement of the retinal nerve fibre layer with scanning laser polarimetry in patients with previous demyelinating optic neuritis. J. Neurol. Neurosurg. Psychiatry 64 (1998) 505-509
29. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., and Bö L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
30. Trip S.A., Schlottmann P.G., Jones S.J., Altmann D.R., Garway-Heath D.F., Thompson A.J., Plant G.T., and Miller D.H. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann. Neurol. 58 (2005) 383-391
31. Wujek J.R., Bjartmar C., Richer E., Ransohoff R.M., Yu M., Tuohy V.K., and Trapp B.D. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropathol. Exp. Neurol. 61 (2002) 23-32